Aragen Bioscience, Inc. and University of Technology, Sydney Enter Into MoU to Support and Accelerate Biologics R&D in Australia
Aragen Bioscience announces the appointment of Steven Lang, PhD, MBA as Vice President, Biologics
Serum Institute and Aragen Bioscience Announce Collaboration on Vaccine Development
GVK BIO announces the appointment of Axel Schleyer, Ph.D. as Chief Executive Officer, Aragen Bioscience, Inc.
Aragen Bioscience Expands Cell Line Development Services